Article
Effect of Losartan on Symptomatic Outpatients with COVID-19: A Randomized Clinical Trial
2021-02-17
Abstract excerpt
Background: The SARS-CoV-2 virus enters cells via the ACE2 receptor, disrupting the renin-angiotensin-aldosterone axis, potentially contributing to lung injury. Treatment with angiotensin receptor blockers(ARBs) may mitigate these effects, though induction of ACE2 expression could increase viral entry, replication, and worsen disease.<br><br>Methods: This study represents a placebo-controlled blinded randomized cl...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e8b622cf-18e4-5d83-b401-a222f99337f3
- DOI
- 10.2139/ssrn.3787463
